Vivendy makes management and board changes
This article was originally published in Scrip
Vivendy Therapeutics(Switzerland) has announced that its chief executive officer, Dr Roland Toder, is stepping down on September 30th. Vivendy has nominated Dr Gosse Bruinsma to its board, and anticipates that this nomination will be ratified at the company's next shareholder meeting. Dr Bruinsma, who most recently served as executive chairman at Curidium Medica, will also assume an executive function, which will encompass the activities of the CEO.